From Protocol to Execution: Navigating Clinical Complexity with End-to-End AI

Session details:

As clinical trials grow increasingly complex, relying on rigid fixed designs and manual, siloed authoring processes is no longer a viable strategy for success. This presentation discusses the practical application of AI across the entire clinical lifecycle, from uncovering responder subgroups and simulating trial designs to optimizing site strategy and automating protocol-to-submission workflows. Join PhaseV's CEO to examine real-world case studies demonstrating how the multimodal AI platform reduces trial cost by up to 50%, shortens trial duration by up to 40%, and increases the probability of success by up to 30%.